Sodium Valproate 200mg CR Tablet PCD Franchise in Mumbai

Antiepileptic Medicine Supplier in Delhi

Epilepsy & Seizure Disorder Tablet Distributor in Chennai

Neurology Pharma Franchise in Pune

Sodium Valproate 200mg Stockist in Kolkata
Antiepileptic Tablet Export & Manufacturing in Hyderabad

Home/Products /valproate-ip-200-mg-tablet

About the Product

Description


Valpotime CR 200 Tablet contains Sodium Valproate 200mg, a controlled-release antiepileptic agent used for the management of epilepsy, seizure disorders, and bipolar disorder. It stabilizes electrical activity in the brain, reducing the frequency and severity of seizures and helping control mood swings.

Belonging to the neurology and psychiatry segment, Valpotime CR 200 is widely prescribed by neurologists and psychiatrists in hospitals, clinics, and mental health centers. Its controlled-release formulation ensures steady therapeutic levels, improving patient compliance and reducing side effects.

Sodium Valproate acts by modulating neurotransmitters in the central nervous system, providing effective symptomatic relief for patients with epilepsy, bipolar disorder, and related neurological conditions.

For PCD pharma franchise partners, distributors, exporters, and third-party manufacturers, Valpotime CR 200 Tablet offers a profitable B2B opportunity. Its high prescription rate and essential therapeutic use ensure a stable demand and strong market presence across India.

Common side effects may include nausea, vomiting, dizziness, drowsiness, or mild gastrointestinal discomfort. Rare but serious effects may include liver toxicity, pancreatitis, severe allergic reactions, or blood disorders. Seek medical attention if you experience jaundice, persistent vomiting, or unusual bruising.

Valpotime CR 200 Tablet is indicated for the treatment of epilepsy, seizure disorders, and bipolar disorder. It helps control generalized, partial, and absence seizures, and can stabilize mood in patients with bipolar disorder.

Take Valpotime CR 200 Tablet exactly as prescribed, preferably with food to reduce gastrointestinal irritation. Do not discontinue suddenly, as this may trigger seizures or mood instability. Inform your doctor if you have liver disease, kidney problems, or are pregnant or planning pregnancy.

Store Valpotime CR 200 Tablet in a cool, dry place below 25°C, away from sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Sodium Valproate IP 200mg Tablet in the PCD pharma franchise market?

Sodium Valproate IP 200mg Tablet has strong demand in the neurology, epilepsy care, psychiatry, and CNS (Central Nervous System) segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on neurological and neuropsychiatric medicine portfolios.

Why should medical distributors include Sodium Valproate IP 200mg Tablet in their product range?

Medical distributors and agencies can benefit from demand for seizure disorder and mood disorder management under specialist supervision. Sodium Valproate IP 200mg is an antiepileptic medication widely used in neurological and psychiatric care Commonly prescribed for the management of epilepsy, seizure disorders, bipolar disorder, and migraine prevention as advised by healthcare professionals Helps stabilize abnormal electrical activity in the brain and supports effective seizure control in appropriate patients Provides a well-established dosage strength suitable for individualized treatment plans and dose titration Oral tablet formulation offers convenient administration for long-term therapy under medical supervision Requires regular monitoring and dosage adjustments based on patient response and clinical requirements Frequently utilized in neurology clinics, psychiatry centers, epilepsy clinics, hospitals, and specialty healthcare facilities Widely prescribed by neurologists, psychiatrists, and CNS specialists This strengthens a comprehensive neurology, epilepsy, and mental healthcare portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Sodium Valproate IP 200mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from consistent prescription demand, specialty healthcare market opportunities, repeat purchases, reliable supply chain support, and attractive margins in the neurology and psychiatry segments.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.